Correlation Between Milestone Pharmaceuticals and INC Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and INC Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and INC Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and INC Research Holdings, you can compare the effects of market volatilities on Milestone Pharmaceuticals and INC Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of INC Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and INC Research.

Diversification Opportunities for Milestone Pharmaceuticals and INC Research

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Milestone and INC is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and INC Research Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INC Research Holdings and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with INC Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INC Research Holdings has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and INC Research go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and INC Research

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the INC Research. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 1.08 times less risky than INC Research. The stock trades about -0.02 of its potential returns per unit of risk. The INC Research Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  220.00  in INC Research Holdings on September 1, 2024 and sell it today you would lose (87.00) from holding INC Research Holdings or give up 39.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Milestone Pharmaceuticals  vs.  INC Research Holdings

 Performance 
       Timeline  
Milestone Pharmaceuticals 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
INC Research Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INC Research Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Milestone Pharmaceuticals and INC Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Milestone Pharmaceuticals and INC Research

The main advantage of trading using opposite Milestone Pharmaceuticals and INC Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, INC Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INC Research will offset losses from the drop in INC Research's long position.
The idea behind Milestone Pharmaceuticals and INC Research Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments